Schedule 13D ownership disclosure

BIOMEA FUSION INC

Common Stock · CUSIP: 09077A106

Event date: 2025-10-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Cormorant Global Healthcare Master Fund, LPReported CIK 0001618442

    Shares: 1,795,928 · Class: 2.59%

  • Cormorant Global Healthcare GP, LLCReported CIK 0001618451

    Shares: 1,795,928 · Class: 2.59%

  • Cormorant Private Healthcare Fund III LPReported CIK 0001817320

    Shares: 1,717,232 · Class: 2.48%

  • Cormorant Private Healthcare GP III, LLC

    Shares: 1,717,232 · Class: 2.48%

  • Cormorant Asset Management, LPReported CIK 0001583977

    Shares: 3,570,872 · Class: 5.15%

  • Chen BihuaReported CIK 0001599214

    Shares: 3,681,664 · Class: 5.31%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-25-003884
Form type
SCHEDULE 13D/A
Filer
Biomea Fusion, Inc.
CIK
CIK 1840439
Filed
Oct 10, 2025
Reporting period
Oct 08, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub